New PSE OTC Requirement – Must start by April 5, 2014

Pharmacy Manager,

This email is to update you on the National Precursor Log Exchange (NPLEx) project in Pennsylvania.  In compliance with HB 602 Act 53 the state has contracted Appriss to deliver NPLEx to all pharmacies/retailers within Pennsylvania.  The NPLEx system enables pharmacies and retailers to easily comply with the Combat Methamphetamine Epidemic Act (CMEA) as well as local and state legislation.  NPLEx provides a free electronic monitoring and compliance solution for all PSE type products along with training and reporting to Law Enforcement.

The effective date for the bill was  July 9th 2013 – the “target” date to implement NPLEx is March 15th 2014. All pharmacies and retailers that sell PSE over the counter must be submitting transactions to NPLEx by April 5th 2014.

NPLEx will be sending a copy of the letter from the Pennsylvania Department of Health detailing the project.  If your store does NOT sell any over the counter cold and allergy medicine containing PSE as the active ingredient, please respond to this email stating your pharmacy name, DEA #, your name, and that you do not sell PSE over the counter.

If you sell over the counter PSE products, please follow these steps:

To use NPLEx, your business needs only an internet connected computer with a standard web browser. Please have only one manager or pharmacist in charge follow the steps below to request a store account:

Go to https://nplex.appriss.com

Click on the “Register a New Account” link in the bottom right

At the top of the next form choose Pharmacy or Non-Pharmacy from the drop down box

Fill out the required information for your store type and click Submit

Please confirm that the email address is valid

Please note that if you have more than one store, you must use a unique email address for each store, email address cannot be associated with more than one store account.

Shortly after you register for your store account, you will receive an email message to the email address provided during registration. This email will provide you with next steps to set up a user account.  Some email systems may send this email to your SPAM folder. Please check this folder if you do not see it in your email inbox. If you do not receive an email within a week of registering, please contact Appriss Implementation Support.

Information on web-based training will be available in the upcoming letter.

Optional Scanner: The NPLEx retail web portal does not require any scanner hardware. However, pharmacies interested in further enhancing their workflow have the option of purchasing scanners that will scan 2D Driver’s License, product UPC, and capture signature. The State of Pennsylvania does NOT require any scanners to participate in NPLEx. If your pharmacy is interested in obtaining more information on a scanner or have additional questions, please email PANPLEx@appriss.com.

Point-of-Sale Integration: Appriss, the software provider of NPLEx, has also completed or is in the process of developing integrations with several point-of-sale (POS) vendors. By integrating with the POS software, transactions can be submitted directly to NPLEx from your POS system instead of using the NPLEx retail web portal. For additional information on whether your POS system can be integrated with NPLEx, please have your POS vendor contact Appriss at PANPLEx@appriss.com.

This project is sponsored by the National Association of Drug Diversion Investigators. Again, there is no charge to your pharmacy for participating in the project or using the NPLEx retail web portal.

If you have any questions regarding the implementation and deployment of NPLEx within Pennsylvania, or general questions regarding accounts and access to the program, please reach out to us at the information provided below and within the letter.

Thank you,

The NPLEx Implementation Team

855.675.3972

PANPLEx@appriss.com